ask="3.90"
ask_size="500"
average_daily_volume="109723"
bid="3.84"
bid_size="100"
book_value="2.54"
change="-0.07"
change_from_200_day_moving_average="-1.27"
change_from_50_day_moving_average="-0.32"
change_from_52_week_high="-7.63"
change_From_52_week_low="0.20"
change_in_percent="-1.74%"
close="3.96"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.51"
ebitda="-74.76M"
eps_estimate_current_year="-1.08"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-1.20"
ex_dividend_date="N/A"
float_shares="24541000"
high="4.15"
high_52_weeks="11.59"
last_trade_date="3/1/2017"
last_trade_price="3.96"
last_trade_size="345"
last_trade_time="3:59pm"
low="3.96"
low_52_weeks="3.76"
market_capitalization="280.31M"
moving_average_200_day="5.23"
moving_average_50_day="4.28"
name="Adaptimmune Therapeutics plc"
notes="N/A"
one_year_target_price="14.83"
open="4.05"
pe_ratio="N/A"
peg_ratio="0.28"
percent_change_from_200_day_moving_average="-24.32%"
percent_change_from_50_day_moving_average="-7.58%"
percent_change_from_52_week_high="-65.83%"
percent_change_from_52_week_low="+5.32%"
previous_close="4.03"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.58"
price_per_sales="29.95"
revenue="9.52M"
shares_outstanding="70785000"
short_ratio="3.03"
stock_exchange="NMS"
symbol="ADAP"
volume="123045"
weeks_range_52="3.76 - 11.59"
